LATS1 and polycystic ovary syndrome: A previous study found that the circulating level of miRNA-21 was significantly increased in PCOS patients, which resulted in decreased expression of MST1/2, LATS1/2, TAZ in PCOS patients when compared to control subjects (Jiang et al., 2015).